Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Express Scripts
Covington
Boehringer Ingelheim
Accenture
McKinsey
Cantor Fitzgerald
Dow
Teva

Generated: January 18, 2018

DrugPatentWatch Database Preview

OXANDROLONE Drug Profile

« Back to Dashboard

Which patents cover Oxandrolone, and when can generic versions of Oxandrolone launch?

Oxandrolone is a drug marketed by Par Pharm, Roxane, Sandoz, and Upsher-smith Labs. and is included in five NDAs.

The generic ingredient in OXANDROLONE is oxandrolone. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the oxandrolone profile page.
Drug patent expirations by year for OXANDROLONE
Medical Subject Heading (MeSH) Categories for OXANDROLONE

US Patents and Regulatory Information for OXANDROLONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm OXANDROLONE oxandrolone TABLET;ORAL 077827-001 Jun 22, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher-smith Labs OXANDROLONE oxandrolone TABLET;ORAL 076761-001 Dec 1, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane OXANDROLONE oxandrolone TABLET;ORAL 077249-002 Jul 10, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher-smith Labs OXANDROLONE oxandrolone TABLET;ORAL 078033-001 Mar 22, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm OXANDROLONE oxandrolone TABLET;ORAL 077827-002 Jun 22, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane OXANDROLONE oxandrolone TABLET;ORAL 077249-001 Jul 10, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz OXANDROLONE oxandrolone TABLET;ORAL 076897-002 Dec 1, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz OXANDROLONE oxandrolone TABLET;ORAL 076897-001 Dec 1, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Julphar
Cerilliant
Boehringer Ingelheim
Citi
Dow
Accenture
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot